109 related articles for article (PubMed ID: 12565127)
1. Importance of IgG2c isotype in the immune response to beta-amyloid in amyloid precursor protein/transgenic mice.
Petrushina I; Tran M; Sadzikava N; Ghochikyan A; Vasilevko V; Agadjanyan MG; Cribbs DH
Neurosci Lett; 2003 Feb; 338(1):5-8. PubMed ID: 12565127
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of anti-Abeta antibody isotypes used for intracerebroventricular immunization in TgCRND8.
Chauhan NB; Siegel GJ
Neurosci Lett; 2005 Mar; 375(3):143-7. PubMed ID: 15694248
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
4. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
[TBL] [Abstract][Full Text] [Related]
5. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42).
Town T; Vendrame M; Patel A; Poetter D; DelleDonne A; Mori T; Smeed R; Crawford F; Klein T; Tan J; Mullan M
J Neuroimmunol; 2002 Nov; 132(1-2):49-59. PubMed ID: 12417433
[TBL] [Abstract][Full Text] [Related]
6. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.
Agadjanyan MG; Ghochikyan A; Petrushina I; Vasilevko V; Movsesyan N; Mkrtichyan M; Saing T; Cribbs DH
J Immunol; 2005 Feb; 174(3):1580-6. PubMed ID: 15661919
[TBL] [Abstract][Full Text] [Related]
7. Measuring of IgG2c isotype instead of IgG2a in immunized C57BL/6 mice with Plasmodium vivax TRAP as a subunit vaccine candidate in order to correct interpretation of Th1 versus Th2 immune response.
Nazeri S; Zakeri S; Mehrizi AA; Sardari S; Djadid ND
Exp Parasitol; 2020 Sep; 216():107944. PubMed ID: 32619431
[TBL] [Abstract][Full Text] [Related]
8. Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice.
Li Q; Cao C; Chackerian B; Schiller J; Gordon M; Ugen KE; Morgan D
BMC Neurosci; 2004 Jun; 5():21. PubMed ID: 15186505
[TBL] [Abstract][Full Text] [Related]
9. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease.
Monsonego A; Maron R; Zota V; Selkoe DJ; Weiner HL
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10273-8. PubMed ID: 11517335
[TBL] [Abstract][Full Text] [Related]
10. Active immunization with the peptide epitope vaccine Aβ3-10-KLH induces a Th2-polarized anti-Aβ antibody response and decreases amyloid plaques in APP/PS1 transgenic mice.
Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
Neurosci Lett; 2016 Nov; 634():1-6. PubMed ID: 27693663
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
Kim HD; Jin JJ; Maxwell JA; Fukuchi K
Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
[TBL] [Abstract][Full Text] [Related]
12. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
Seabrook TJ; Thomas K; Jiang L; Bloom J; Spooner E; Maier M; Bitan G; Lemere CA
Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229
[TBL] [Abstract][Full Text] [Related]
13. The need for IgG2c specific antiserum when isotyping antibodies from C57BL/6 and NOD mice.
Martin RM; Brady JL; Lew AM
J Immunol Methods; 1998 Mar; 212(2):187-92. PubMed ID: 9672206
[TBL] [Abstract][Full Text] [Related]
14. DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
Lambracht-Washington D; Qu BX; Fu M; Eagar TN; Stüve O; Rosenberg RN
JAMA; 2009 Oct; 302(16):1796-802. PubMed ID: 19861672
[TBL] [Abstract][Full Text] [Related]
15. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific versus total immunoglobulin synthesis: total IgE and IgG1, but not IgG2a levels predict murine antigen-specific responses.
Lewkowich IP; Rempel JD; HayGlass KT
Int Arch Allergy Immunol; 2004 Feb; 133(2):145-53. PubMed ID: 14745227
[TBL] [Abstract][Full Text] [Related]
17. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
[TBL] [Abstract][Full Text] [Related]
18. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
Sin JI; Bagarazzi M; Pachuk C; Weiner DB
DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
[TBL] [Abstract][Full Text] [Related]
19. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice.
Guery JC; Galbiati F; Smiroldo S; Adorini L
J Exp Med; 1996 Feb; 183(2):485-97. PubMed ID: 8627161
[TBL] [Abstract][Full Text] [Related]
20. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
Chackerian B; Rangel M; Hunter Z; Peabody DS
Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
